Study Protocol for Feasibility Randomized, Placebo-Controlled Trial of Efficacy of Midazolam as the Second-Line Treatment for Dyspnea in Patients with Advanced Cancer.

Miwa S, Mori M, Oyamada S, Yamaguchi T, Ariyoshi K, Matsuda Y, Suzuki K, Tasaki J, Hatano Y, Nishijima K, Aiki S, Hagimoto S, Kuriyama T, Okuda Y, Tashiro S, Matsumoto Y, Hashimoto H, Kawaguchi T, Ishiguro H, Zenda S, Matsuoka H, Hui D, Morita T, Yamaguchi T

Open source

DOI: 10.1177/26892820261461866
Published: 2026 Jan-Dec
Container: Palliative medicine reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/26892820261461866,
  title = {Study Protocol for Feasibility Randomized, Placebo-Controlled Trial of Efficacy of Midazolam as the Second-Line Treatment for Dyspnea in Patients with Advanced Cancer.},
  author = {Miwa S and Mori M and Oyamada S and Yamaguchi T and Ariyoshi K and Matsuda Y and Suzuki K and Tasaki J and Hatano Y and Nishijima K and Aiki S and Hagimoto S and Kuriyama T and Okuda Y and Tashiro S and Matsumoto Y and Hashimoto H and Kawaguchi T and Ishiguro H and Zenda S and Matsuoka H and Hui D and Morita T and Yamaguchi T},
  year = {2026},
  journal = {Palliative medicine reports},
  doi = {10.1177/26892820261461866},
  url = {https://doi.org/10.1177/26892820261461866}
}

RIS

TY  - JOUR
TI  - Study Protocol for Feasibility Randomized, Placebo-Controlled Trial of Efficacy of Midazolam as the Second-Line Treatment for Dyspnea in Patients with Advanced Cancer.
AU  - Miwa S
AU  - Mori M
AU  - Oyamada S
AU  - Yamaguchi T
AU  - Ariyoshi K
AU  - Matsuda Y
AU  - Suzuki K
AU  - Tasaki J
AU  - Hatano Y
AU  - Nishijima K
AU  - Aiki S
AU  - Hagimoto S
AU  - Kuriyama T
AU  - Okuda Y
AU  - Tashiro S
AU  - Matsumoto Y
AU  - Hashimoto H
AU  - Kawaguchi T
AU  - Ishiguro H
AU  - Zenda S
AU  - Matsuoka H
AU  - Hui D
AU  - Morita T
AU  - Yamaguchi T
PY  - 2026
JO  - Palliative medicine reports
DO  - 10.1177/26892820261461866
UR  - https://doi.org/10.1177/26892820261461866
ER  -

APA

S, M., M, M., S, O., T, Y., K, A., Y, M., K, S., J, T., Y, H., K, N., S, A., S, H., T, K., Y, O., S, T., Y, M., H, H., T, K., H, I., S, Z., H, M., D, H., T, M., & T, Y. (2026). Study Protocol for Feasibility Randomized, Placebo-Controlled Trial of Efficacy of Midazolam as the Second-Line Treatment for Dyspnea in Patients with Advanced Cancer.. Palliative medicine reports. https://doi.org/10.1177/26892820261461866

Source records

pubmed · retrieved 2026-09-26T12:06:04.650Z